S 1388 United States Senate · 117th Congress

Prescription Pricing for the People Act of 2021

Summary
Prescription Pricing for the People Act of 20 21 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 27, 2021 Last action Jul 29, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
2
Jul 29, 2021
Upper · Passed
Committee on the Judiciary. Ordered to be reported without amendment favorably.
upper
Apr 27, 2021
Committee
Read twice and referred to the Committee on the Judiciary.
upper
Apr 27, 2021
Introduced
Introduced in Senate
upper
1 primary · 10 co-sponsors

Sponsors